๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Personalized medicine prompts push to redesign clinical trials

โœ Scribed by Singer, Emily

Book ID
109928318
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
134 KB
Volume
11
Category
Article
ISSN
1078-8956

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Personalized medicine in hepatitis C: Fr
Personalized medicine in hepatitis C: From genome-wide association studies to clinical practice
โœ Hermann E. Wasmuth; Ralf Weiskirchen ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 365 KB ๐Ÿ‘ 1 views

Nonalcoholic steatosis (fatty liver) is a major cause of liver dysfunction that is associated with insulin resistance and metabolic syndrome. The cJun NH 2 -terminal kinase 1 (JNK1) signaling pathway is implicated in the pathogenesis of hepatic steatosis and drugs that target JNK1 may be useful for